To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to help plans identify members likely to experience increases in pharmacy costs.

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.

A legislative insurance panel on Wednesday approved the state Employee Benefits Division's proposals to boost the ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...

Millions of Americans aged 65 and older rely on Medicare Part D to manage the cost of their prescription medications. As the healthcare landscape shifts, this crucial benefit faces financial and ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a ...

A spike in income could result in costly IRMAA charges on your Medicare premiums. We ask financial planning experts for ...

While Medicare can now negotiate some drug prices under the Inflation Reduction Act of 2022, these measures will only impact a limited number of medications and take years to implement fully.

New Medicare changes are here, offering major cost savings for retirees. Learn about 8 expenses you may no longer have to pay, from insulin to drug costs.

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

Medicare may cover Revlimid (lenalidomide) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Revlimid is a brand-name drug that doctors ...

The recently passed “Big Beautiful Bill,’’ among its many deficiencies, contains changes that will negatively impact the ...